Home/Filings/4/0001104659-24-032409
4//SEC Filing

Raphael Erez 4

Accession 0001104659-24-032409

CIK 0001533998other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 4:19 PM ET

Size

6.1 KB

Accession

0001104659-24-032409

Insider Transaction Report

Form 4
Period: 2024-03-06
Raphael Erez
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2024-03-06+800,0001,912,059 total
Holdings
  • Common Stock

    (indirect: By Dicilyon Consulting and Investment Ltd.)
    37,876
Footnotes (2)
  • [F1]The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in quarterly instalments on the last day of each calendar quarter commencing March 31, 2024 for a two year period.
  • [F2]The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.

Issuer

DarioHealth Corp.

CIK 0001533998

Entity typeother

Related Parties

1
  • filerCIK 0001668046

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:19 PM ET
Size
6.1 KB